Monday, January 05, 2026 | 09:20 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Venus forays into Singapore's topical pain management market

Image

Capital Market

With marketing approval and patent for Trois

Venus Remedies announced that the Company has entered into Singapore's topical pain management market with a marketing authorisation and patent for its herbal nanotechnology based pain reliever Trois. The Company is holding talks with various pharmaceutical firms for tie-ups to market Trois in Singapore.

Powered by Capital Market - Live News

 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 25 2014 | 12:20 PM IST

Explore News